KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Zimmer Biomet Holdings (ZBH) EPS (Weighted Average and Diluted) (2016 - 2026)

Zimmer Biomet Holdings has reported EPS (Weighted Average and Diluted) over the past 18 years, most recently at $1.22 for Q1 2026.

  • For Q1 2026, EPS (Weighted Average and Diluted) rose 34.07% year-over-year to $1.22; the TTM value through Mar 2026 reached $3.86, down 14.41%, while the annual FY2025 figure was $3.55, 19.86% down from the prior year.
  • EPS (Weighted Average and Diluted) for Q1 2026 was $1.22 at Zimmer Biomet Holdings, up from $0.71 in the prior quarter.
  • Over five years, EPS (Weighted Average and Diluted) peaked at $2.0 in Q4 2023 and troughed at -$0.62 in Q4 2022.
  • A 5-year average of $0.89 and a median of $0.92 in 2022 define the central range for EPS (Weighted Average and Diluted).
  • Biggest five-year swings in EPS (Weighted Average and Diluted): tumbled 92.55% in 2022 and later skyrocketed 1485.71% in 2023.
  • Year by year, EPS (Weighted Average and Diluted) stood at -$0.62 in 2022, then surged by 422.58% to $2.0 in 2023, then tumbled by 40.5% to $1.19 in 2024, then crashed by 40.34% to $0.71 in 2025, then surged by 71.83% to $1.22 in 2026.
  • Business Quant data shows EPS (Weighted Average and Diluted) for ZBH at $1.22 in Q1 2026, $0.71 in Q4 2025, and $1.16 in Q3 2025.